Tier 3 — preclinical

The nature of endothelium-derived vascular relaxant factor

Griffith TM, Edwards DH, Lewis MJ, Newby AC, Henderson AH
Nature 1984 Volume 308, Issue 5960, pages 645-647

Bibliography

PubMed
PMID 6424031
Funding
Supported by the British Heart Foundation.

Study snapshot

DesignControlled laboratory bioassay (cascade superfusion) study
ModelIsolated rabbit aortic strip preparations, alone and in cascade with isolated perfused rabbit coronary artery preparations
SampleNot applicable (isolated tissue/bioassay study; N not reported as a subject count)
InterventionAcetylcholine-stimulated release of EDRF from endothelium-containing aortic strips, tested for humoral transfer via cascade superfusion onto coronary artery preparations
DurationNot applicable (acute in vitro/ex vivo experiments)
EndpointsDemonstration that EDRF is a humoral (diffusible) agent releasable independently of stimulation and transferable in cascade bioassay; Time course and stability characteristics of EDRF release stimulated by acetylcholine; Chemical characterization of EDRF as an unstable compound with a carbonyl group at or near its active site (later shown to be incorrect)

What the study showed, in plain terms

This 1984 Nature paper, published three years before nitric oxide was identified as the answer, was an important early step in the scientific detective story of "endothelium-derived relaxing factor" (EDRF), a then-mysterious substance released by the cells lining blood vessels that causes surrounding muscle to relax and vessels to widen.

Using isolated rabbit blood vessel preparations, the researchers proved that EDRF is a true "humoral" substance, meaning it is a diffusible chemical messenger that can travel from where it's made to have effects elsewhere, rather than requiring direct nerve contact or physical touch between cells. They also proposed a specific chemical identity for EDRF: an unstable compound containing a carbonyl group (a type of chemical structure found in aldehydes and ketones).

This specific chemical proposal turned out to be incorrect: three years later, in 1987, two independent research teams (Ignarro's and Moncada's) showed conclusively that EDRF is actually nitric oxide, a simple gas. This paper remains historically valuable for its rigorous proof that EDRF is a genuine diffusible messenger molecule, even though its guess about EDRF's precise chemical structure did not hold up.

Key findings

  • EDRF was demonstrated to be a humoral agent released from unstimulated aortic preparations containing endothelium, distinguishing it from a directly nerve-mediated or contact-dependent effect.
  • EDRF release could be stimulated for prolonged periods by acetylcholine, and its activity was transferable via cascade superfusion onto separate coronary artery preparations.
  • The authors concluded EDRF was not a lipoxygenase derivative or free radical, but rather an unstable compound with a carbonyl group at or near its active site — a chemical identity later shown to be incorrect when EDRF was identified as nitric oxide in 1987.

What this study can and cannot tell us

This paper's central conclusion — that EDRF is an unstable carbonyl-containing compound — was superseded three years later when independent groups (Ignarro et al., 1987; Palmer, Ferrige & Moncada, 1987) conclusively identified EDRF as nitric oxide. This entry is retained in the corpus for its important historical and methodological contribution (proving EDRF's humoral nature), not as a source of accurate chemical-identity claims; readers should rely on the 1987 papers for the correct chemical identity of EDRF.

This is a preclinical, isolated-tissue bioassay study in rabbits, not a human or intact-animal cardiovascular study.

Citation network

Articles citing this research paper

1 article

Biohack Blueprint analyses that reference this study in their evidence base.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified